| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757619A2 Osteoprotegerin in milk |
| 02/28/2007 | EP1757606A1 Xanthinderivatives, preparation thereof and their use as medical agents |
| 02/28/2007 | EP1757602A1 Vla-4 inhibitor |
| 02/28/2007 | EP1757321A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 02/28/2007 | EP1757285A1 Preventive and/or therapeutic agent for chronic sinusitis |
| 02/28/2007 | EP1757281A2 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 02/28/2007 | EP1757275A1 Seamless capsule containing water-soluble active ingredient |
| 02/28/2007 | EP1756164A2 Dr5 antibodies and uses thereof |
| 02/28/2007 | EP1756133A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1 |
| 02/28/2007 | EP1756111A1 Alkyl substituted indoloquinoxalines |
| 02/28/2007 | EP1756108A2 Azaindoles useful as inhibitors of rock and other protein kinases |
| 02/28/2007 | EP1755680A1 Combinations comprising a s1p receptor agonist and a jak3 kinase inhibitor |
| 02/28/2007 | EP1755604A2 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 02/28/2007 | EP1755603A2 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity |
| 02/28/2007 | EP1551375B1 Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1482951B8 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 02/28/2007 | EP1456197B1 Piperidine-2,6-diones that are heterocyclically substituted in position 3 |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1320541B1 Tgf-beta inhibitors and methods |
| 02/28/2007 | EP1309592B9 Substituted pyrazoles |
| 02/28/2007 | EP1276491B9 Tamandarin and didemnin analogs and methods of making and using them |
| 02/28/2007 | EP1272186B1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1254240B1 Hybrid protease with reduced antigenicity and its use |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | EP1091928B1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| 02/28/2007 | EP1073737B1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/28/2007 | EP1024827B1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 02/28/2007 | EP0888122B1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 02/28/2007 | CN1922316A Mutants of anti-cd40 antibody |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922158A Isothiourea derivatives |
| 02/28/2007 | CN1922148A Pyrazole derivatives as protein kinase modulators |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921886A Methods of modulating cytokine activity, related reagents |
| 02/28/2007 | CN1921872A Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation of PPR-gamma receptors |
| 02/28/2007 | CN1921862A Immunostimulant composition comprising at least one TOLL-like receptor 7 or TOLL-like receptor 8 agonist and a TOLL-like receptor 4 agonist |
| 02/28/2007 | CN1921847A 氨基醇化合物 Amino alcohol compound |
| 02/28/2007 | CN1921841A Amines and amides for the treatment of diseases |
| 02/28/2007 | CN1919848A bilobalide K and complex thereof, preparation method and use for the same |
| 02/28/2007 | CN1919307A Quality controlling means of traditional medicine Injectio |
| 02/28/2007 | CN1919306A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919305A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919304A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919303A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919302A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919301A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919300A Traditional medicine Injectio and its preparing method |
| 02/28/2007 | CN1919287A Bee glue capsule |
| 02/28/2007 | CN1919270A Composition, exract, and pharmaceutical use thereof |
| 02/28/2007 | CN1919194A Liquid composition of sirolimus |
| 02/28/2007 | CN1919191A Application of ring icariine in the preparation of medicine for preventing and treating organ transplantation rejection |
| 02/28/2007 | CN1919184A Mycophenolate mofetile dispersed tablet and preparation method thereof |
| 02/28/2007 | CN1302113C Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
| 02/28/2007 | CN1302103C CD 19XCD3 specific polypeptides and uses thereof |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301997C Benzosulfones with calcium antagonist activity |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CA2538408A1 Diet product, oral drug and method for treating allergies using tgf-.beta.1 |
| 02/27/2007 | US7183390 Humanized antibodies to gamma-interferon |
| 02/27/2007 | US7183389 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183275 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 02/27/2007 | US7183274 Piperidine-2,6-diones heterocyclically substituted in the 3-position |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183112 Administering locally to the area of inflammation to an animal an anti-inflammatory effective amount of an anti-malaria compound which is aminoquinoline or derivative |
| 02/27/2007 | US7183111 Immunomodulatory formulations and methods for use thereof |
| 02/27/2007 | US7183108 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183065 Diagnosing ulcerative colitis in humans; obtain sample tissue, incubate with histone antigen, detect presence of complex formation, presence of complex indicates ulcerative colitis |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | CA2240281C Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 02/22/2007 | WO2007022511A2 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 02/22/2007 | WO2007021020A1 Capsinoid containing composition |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020411A1 Amide derivatives |
| 02/22/2007 | WO2007020018A1 Use of purinergic and pyrimidinergic receptor agonists for dendritic cells based immunotherapies |
| 02/22/2007 | WO2007019618A1 Phrophylactic and/or therapeutic method for treatment of autoimmune disease |
| 02/22/2007 | WO2006135385A3 Antagonizing interleukin-21 receptor activity |
| 02/22/2007 | WO2006134190A3 Agents and methods based on the use of the eda domain of fibronectin |
| 02/22/2007 | WO2006103472A3 Soluble vox2 protein as immunoregulatory factor |
| 02/22/2007 | WO2006091897A3 Derivatives of 8-substituted xanthines |
| 02/22/2007 | WO2006091896A3 Pyridyl substituted xanthines |
| 02/22/2007 | WO2006069202A3 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies |
| 02/22/2007 | WO2006068978A3 Dipeptidyl peptidase inhibitors |
| 02/22/2007 | WO2006059169A3 Antiviral and immunostimulating marine fish oil composition |
| 02/22/2007 | US20070043206 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |